Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., a national high-tech biopharmaceutical enterprise, was established in April 2009 and located in Jiangyin High-tech Development Zone, Jiangsu Province. The company focused on the research, development and production of peptide and chemical drugs. Our Research & Development (R & D) colleagues are Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd. , Nanjing Denovo Pharmaceutical Technology Co., Ltd. , Jiangsu Putai Pharmaceutical Technology Co., Ltd. , ProteLight Medical Holdings (Hong Kong) Co., Ltd. and ProteLight Phamaceuticals (Australia) Pty Ltd.
Based on the innovative R&D core strategy, our product pipeline was strongly established, such as several first-in-class peptide new drug in anti-infective and anti-cancer area. Several national first-in-class innovative drug research projects are ongoing. Our company has obtained multiple patents, including PCT patents, US and EU and CN patents, utility models and appearance patents and so on.
Since its establishment, our company has undertaken more than 40 scientific research projects, including the National Health Commission’s 12th and 13th Five-Year "Major New Drug Creation" science and technology projects, and the Ministry of Human Resources and Social Security "Selected funding for scientific and technological innovation and entrepreneurship projects for overseas students".
In the future, our company will maintain and strengthen R&D and production, and pursue high-quality innovative products to expand the market, and strive to become the leader of international antimicrobial peptide pharmaceutical enterprises!